Journal Guide

This is a Subscribe to Open journal. The below estimate Article Processing Charges (APCs) are $0.00 but additional page charges will apply. More information here.

Antimicrobial Agents and Chemotherapy® features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. The journal also publishes studies involving animal models, pharmacological characterization, and clinical trials.

Antimicrobial Resistance and Infection Control is a global forum for reports encompassing all aspects of resistance development and prevention of health-care associated infections in all health-care settings Antimicrobial Resistance and Infection Control aims to be a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. Infection Control wishes to cover a broad spectrum of 'preeminent practices' and 'best available data' to the 'best interventional and translational research' and innovative (technical) developments in the field of infection control.Antimicrobial Resistance and Infection Control believes that a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, possibilities to prevent transmission and infections and insight into the difference between developed countries and countries with limited resources are key-factors to find future solutions. Antimicrobial Resistance and Infection Control needs to combine best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. Antimicrobial Resistance and Infection Control welcomes all manuscripts related to the filed of HAI prevention and infection control. Some examples are listed below: Prevention of health-care associated infection in hospitals.Infection control and antimicrobial-resistance in high-risk settings (e.g. ICUs).HAI prevention and antimicrobial-resistance in special settings e.g. long-term care facilities.Infection control and antimicrobial-resistance in community settings.Special problems with Infection control and antimicrobial-resistance in resource-limited countries.

pharmacodynamics

Antioxidants & Redox Signaling is the leading journal dedicated to the understanding of reactive species as messenger molecules regulating signal transduction and gene expression. New research reveals that radicals, which have been known as damaging agents, can have the potential to be used for therapeutic purposes. This journal uncovers the expanding world of redox-based therapeutics—genetic, pharmacological, and nutritional.

For over 40 years Antipode has published dissenting scholarship that explores and utilizes key geographical ideas like space, scale, place, borders and landscape. It aims to challenge dominant and orthodox views of the world through debate, scholarship and politically-committed research, creating new spaces and envisioning new futures. Antipode welcomes the infusion of new ideas and the shaking up of old positions, without being committed to just one view of radical analysis or politics.

Antiviral Chemistry & Chemotherapy is a peer-reviewed open access journal which focuses on all aspects of antiviral compounds, including their chemistry, therapeutic effects, biochemistry, pharmacology, mode of action, and virology. This journal is a member of the Committee on Publication Ethics (COPE).

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action;new or improved vaccines against viral infections of humans and animals;assessments of drug and vaccine safety;evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;identification and validation of new drug targets;laboratory animal models of viral diseases;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com).Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2009 ISI impact factor: 4.32).The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.